Report Publication Announcement • May 29, 2024
Report Publication Announcement
Open in ViewerOpens in native device viewer
Lifecare ASA: FAQ regarding Rights Issue
Reference is made to the previous stock exchange announcements published by
Lifecare ASA ("Lifecare" or the "Company") regarding the partially
underwritten rights issue.
Frequently asked questions (FAQ) on the Rights Issue is avalaible in the
attachment.
About us
Lifecare ASA is a clinical stage medical sensor company developing technology
for sensing and monitoring of various body analytes. Lifecare's main focus is
to bring the next generation of Continuous Glucose Monitoring ("CGM") systems
to market. Lifecare enables osmotic pressure as sensing principle, combined
with the ability to manipulate Nano-granular Tunnelling Resistive sensors
("NTR") on the sensor body for read-out of pressure variations. Lifecare's
sensor technology is referred to as "Sencell" and is suitable for identifying
and monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, [email protected], +47 40 05 90 40
Renete Kaarvik, CFO, [email protected], +47 94 83 82 42
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.